OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
April 01, 2009
From the depths of the Great Recession, Pharm Exec called in pros on all sides of the M&A business to help us deal.
Launching a product? Your competition likely plans to interfere. Here's how to counter a counter-launch.
How one conversation between a woman and her physician can make or break a brand
Layoffs are raging through the economy. But do they actually affect the bottom line
From her start as a physician working in apartheid-era South Africa to the dramatic turnaround and takeover of Millennium, Deborah Dunsire has lived a life that has defied all expectations.
Big Pharma is finally making a commitment to partner-based outsourcing.
In addition to overhauling healthcare, Congress is weighing proposals for updating FDA policies and expanding access to drugs.
It's time for pharma market research to advance science-based decisions and foster judgement calls
From the Editor
Unsolicited advice for FDA's next leader: Keep it real, fight popular delusions, and somehow, please, defend the agency.